ArticleBiomolecules2021

A Combination of Glutaminase Inhibitor 968 and PD-L1 Blockade Boosts the Immune Response against Ovarian Cancer.

Jing-Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.